Advanced Filters
noise

A, Kuopio N Clinical Trials

A listing of A, Kuopio N clinical trials actively recruiting patients volunteers.

Found 11,558 clinical trials
J Josephine Savard

A Group Based Psychoeducational Intervention for Partners of Child Sexual Abuse Material Offenders.

The overall aim of this feasibility study is to investigate the clinical characteristics of female partners of male child sexual abuse material (CSAM) offenders and to evaluate the feasibility of a novel psychoeducational group intervention designed to address their specific needs. The main questions it aims to answer are: What …

18 years of age Female Phase N/A

A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants

The main aim of the study is to evaluate the pharmacokinetic (PK) biosimilarity of B-3E07 and European Union (EU) - sourced Forsteo® in healthy adult female participants.

18 - 45 years of age Female Phase 1
M Marianne Smith

USE LESS, a Comparative Cohort Study of Climate Change Impact From Orthopedic Surgery

A prospective comparative cohort study with the objective to quantify and compare carbon dioxide equivalent (CO₂e) emissions from orthopedic surgeries performed in two different operating room (OR) settings using different sets of materials and staff.

18 years of age All Phase N/A
V Vít Navrátil, MUDr, Ph.D.

Development of a Preparation for Supportive Supplementation of Probiotics in Patients With Reflux

A two-arm, double-blind, randomized, placebo-controlled study investigating the efficacy of a probiotic preparation developed as supportive supplementation of probiotics in patients with reflux. The objective of this trial is to evaluate the effect of the probiotic dietary supplement on the diversity and composition of the gut microbiome in patients diagnosed …

40 - 55 years of age All Phase 0
Z Zachary Riley

Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task

Virtual reality as a gaming method is being used more regularly due to its immersive environments and total body playability. A few studies have used VR paired with brain stimulation as a clinical treatment for PTSD (van't Wout-Frank et al. 2024), as well as for regaining movement and cognitive abilities …

18 - 45 years of age All Phase N/A
A ASCEND-IBD Trial Center

A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy Participants

A Phase 1, Open-Label, Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MT-201 Administered with Concomitant Infliximab in Healthy Participants

19 - 55 years of age All Phase 1
M Myrna Achkar-Helou, MD

Evaluation of the Nutritional Value of a New Hydrolysed Rice Protein-based Formula

The goal of this interventional clinical trial is to compare the growth parameters of healthy term infants fed either a new experimental rice hydrolyzed rice protein-based formula or a control formula (standard cow's milk protein-based formula), from their study enrollment until the age of 4 months (postnatal age of 120 …

7 - 13 years of age All Phase N/A
E Emma Rheel, PhD

Pain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study

Children living beyond cancer (CBC) represent a unique and growing population of young people in need of long-term clinical support. Studies suggest that 11-44% of CBC experience chronic pain, negatively impacting a wide range of child biopsychosocial outcomes and creating high financial burden for their families and society. Often comorbid …

6 - 12 years of age All Phase N/A
Q Qiang Xia, MD, PhD

A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors

TQB6426 is a glypican-3 (GPC3)-targeted antibody-drug conjugate (ADC) independently developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Preclinical studies have demonstrated its potent anti-tumor activity coupled with a favorable therapeutic safety window, which provides sufficient pharmacological and toxicological evidence to support the initiation of human clinical trials.

18 - 75 years of age All Phase 1
X Xiaohua Wu, M.D

A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors

This is a Phase Ia/Ib, dose escalation and dose expansion study to evaluate the safety, tolerability, PK, and preliminary efficacy of HW221043 tablets in participants with advanced solid tumors. It includes two parts: the dose escalation study (Phase Ia) and the dose expansion study (Phase Ib).

18 years of age All Phase 1

Simplify language using AI